title: Intact pericellular matrix of articular cartilage is required for unactivated discoidin domain receptor 2 in the mouse model.
abstract: Increased expression of the discoidin domain receptor 2 (DDR2) results from its interaction with collagen type II. This induces expression of matrix metalloproteinase (MMP)-13, leading to osteoarthritis (OA). To investigate the impact of the pericellular matrix of chondrocytes on DDR2, we generated a mouse model with inducible overexpression of DDR2 in cartilage. Conditional overexpression of DDR2 in mature mouse articular cartilage was controlled via the cartilage oligomeric matrix protein promoter using the Tet-Off-inducible system. Doxycycline was withdrawn at 1 month of age, and knee joints were examined at 2, 3, and 4 months of age. Microsurgery was performed on 3-month-old transgenic mice overexpressing DDR2 to destabilize the medial meniscus, and serial paraffin sections were examined at 2, 4, 8, and 12 weeks after surgery. DDR2 expression increased in the knee joints of transgenic mice. However, the increased DDR2 did not induce MMP-13 expression. No OA-like changes were observed in the transgenic mice at the age of 4 months. When transgenic mice were subjected to destabilizing of the medial meniscus, we observed accelerated progression to OA, which was associated with DDR2 activation. Therefore, conditionally overexpressing DDR2 in the mature articular cartilage of mouse knee joints requires activation to induce OA, and altered biomechanical stress can accelerate the onset of cartilage loss and progression to OA in transgenic mice.
authors.affiliation: Department of Developmental Biology, Harvard School of Dental Medicine, Boston, Massachusetts, USA. lin_xu@hms.harvard.edu.
authors.forename: Lin
authors.initials: L
authors.lastname: Xu
authors.forename: Ilona
authors.initials: I
authors.lastname: Polur
authors.forename: Jacqueline M
authors.initials: JM
authors.lastname: Servais
authors.forename: Sirena
authors.initials: S
authors.lastname: Hsieh
authors.forename: Peter L
authors.initials: PL
authors.lastname: Lee
authors.forename: Mary B
authors.initials: MB
authors.lastname: Goldring
authors.forename: Yefu
authors.initials: Y
authors.lastname: Li
mesh_terms: D000818:Animals; D002358:Cartilage, Articular / Q000378:metabolism*; D024043:Collagen Type II / Q000378:metabolism; D024141:Collagen Type IV; D000070818:Discoidin Domain Receptors; D004318:Doxycycline / Q000494:pharmacology; D007150:Immunohistochemistry; D053509:Matrix Metalloproteinase 13 / Q000378:metabolism*; D051379:Mice; D008822:Mice, Transgenic; D020370:Osteoarthritis, Knee / Q000209:etiology / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism*; D011975:Receptors, Mitogen / Q000378:metabolism*; D013264:Stifle / Q000378:metabolism*; D019076:Transgenes
chemical_list: C447413:Col2a1 protein, mouse; D024043:Collagen Type II; D024141:Collagen Type IV; D012333:RNA, Messenger; D011975:Receptors, Mitogen; D000070818:Discoidin Domain Receptors; D020794:Receptor Protein-Tyrosine Kinases; D053509:Matrix Metalloproteinase 13; D004318:Doxycycline